Ci3 Cluster (Cluster für Individualisierte ImmunIntervention e. V.)

http://www.ci-3.de

The CI3 excellence cluster pools the outstanding expertise in the Rhine-Main cluster region of Germany involving innovative new therapies and diagnostics in the field of individualised immune intervention. To this end, CI3 is putting together a network of players from the business, research and healthcare communities as well as government and is shaping the integral element across the entire innovation and value creation chain. *

	Start	2011-04-14 existent
	Industry	pharmacogenomics/pharmacogenetics
	Person	Türeci, Özlem (Ganymed 200811 CEO + CSO)
	Person 2	Wessel, Rainer (DKFZ 201906– before CI3 Cluster Manager before Ganymed CEO)

	Region	Mainz
	Country	Germany
	Street	17–19 Kupferbergterrasse
	City	55116 Mainz
	Tel	+49-6131-6230581
		Address record changed: 2018-07-24

Basic data	Employees	n. a.

		* Document for ï¿½About Sectionï¿½: Zedira GmbH. (6/25/12). "Press Release: Zedira, Dr. Falk Phama and the University of Mainz Hospital, which Together Comprise a Flagship Project of the CI3 Excellence Cluster, Are to Receive Subsidy Funding for Clinical Development of a Celiac Disease Dru

		Record changed: 2020-01-01

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

More documents for Ci3 Cluster (Cluster für Individualisierte ImmunIntervention e. V.)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]